NCT02211807 Suicidality and Suicide Attempt Among HIV Patients on Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens Status COMPLETED Phase N/A
NCT02211469 A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02208882 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120 Status COMPLETED Phase PHASE1
NCT02196961 Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation Status COMPLETED Phase PHASE2
NCT02186249 Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Status NO_LONGER_AVAILABLE Phase N/A
NCT02181738 Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) Status COMPLETED Phase PHASE2
NCT02175966 Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study) Status COMPLETED Phase PHASE2
NCT02175602 Study of Drug Combination on Pharmacokinetics in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02170727 A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1 Status COMPLETED Phase PHASE3
NCT02169544 Post-marketing Study Assessing the Long-Term Safety of Abatacept Status COMPLETED Phase N/A
NCT02164812 Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02161939 A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C Status NO_LONGER_AVAILABLE Phase N/A
NCT02161406 A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT02160639 Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support Status UNKNOWN Phase NA
NCT02159365 Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients Status COMPLETED Phase PHASE2
NCT02159352 Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants Status COMPLETED Phase PHASE1
NCT02157506 A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure Status COMPLETED Phase PHASE2
NCT02156804 A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172) Status COMPLETED Phase PHASE2